Canadian immunotherapy holds promise for patients with brain cancer
Glioblastoma multiforme – MRTT2 ax landscape “patient brain scan with glioblastoma shown in red.” Creative Commons. In 2015, Jason Moffat walked into Sheila Singh’s office at McMaster University and gave her a small vial of clear liquid. The vial contained ten milliliters, or two teaspoons, of an injectable antibody, created in Moffat’s lab in Toronto, with a street value of around $100,000. “You better be careful with that,†Singh remembers Moffat telling her at the…